Goldman

There are 4 reasons the stock market is poised to keep soaring to record highs, Goldman Sachs says
There are 4 reasons the stock market is poised to keep soaring to record highs, Goldman Sachs says
finance.yahoo.com
13
Like
Save
Goldman Sachs Says ‘Buy AI Beneficiaries Beyond the High Momentum Stocks’; Here Are 3 Names to Consider
Goldman Sachs Says ‘Buy AI Beneficiaries Beyond the High Momentum Stocks’; Here Are 3 Names to Consider
finance.yahoo.com
10
Like
Save
'I could've been set for life': This former Goldman Sachs analyst says his family of 4 can't live comfortably on $230K a year after buying 'forever home.' Is the American dream out of reach?
'I could've been set for life': This former Goldman Sachs analyst says his family of 4 can't live comfortably on $230K a year after buying 'forever home.' Is the American dream out of reach?
finance.yahoo.com
10
Like
Save
Goldman Says Momentum Traders to Sell Stocks in ‘Every Scenario’
Goldman Says Momentum Traders to Sell Stocks in ‘Every Scenario’
finance.yahoo.com
12
Like
Save
Goldman Says ‘Buy the Dip’ If Stocks Drop After Repricing Fed Cuts
Goldman Says ‘Buy the Dip’ If Stocks Drop After Repricing Fed Cuts
finance.yahoo.com
11
Like
Save
Oil prices could shoot up to $100 a barrel amid a barrage of supply disruption risks in 2024, Goldman Sachs says
Oil prices could shoot up to $100 a barrel amid a barrage of supply disruption risks in 2024, Goldman Sachs says
finance.yahoo.com
23
Like
Save
Here's why the Magnificent 7 tech stocks will continue to outperform the S&P 493 in 2024, according to Goldman Sachs
Here's why the Magnificent 7 tech stocks will continue to outperform the S&P 493 in 2024, according to Goldman Sachs
finance.yahoo.com
18
Like
Save
'The hard part is over': Here's what Goldman Sachs sees in the year ahead as markets and the economy return to pre-2008 conditions
'The hard part is over': Here's what Goldman Sachs sees in the year ahead as markets and the economy return to pre-2008 conditions
finance.yahoo.com
6
Like
Save
Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says
Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says
finance.yahoo.com
23
Like
Save
Goldman Sachs Stock Is Below Book Value. It’s a Great Time to Buy.
Goldman Sachs Stock Is Below Book Value. It’s a Great Time to Buy.
www.barrons.com
21
Like
Save